Umit Topaloglu
Overview
Explore the profile of Umit Topaloglu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
83
Citations
1387
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tyagi A, Wu S, Sharma S, Wu K, Zhao D, Deshpande R, et al.
Oncogene
. 2025 Jan;
44(5):339.
PMID: 39789166
No abstract available.
2.
Adams M, Griffin C, Adams H, Bryant S, Hurley R, Topaloglu U
J Biomed Inform
. 2024 Nov;
159:104749.
PMID: 39510367
Objective: This study aims to provide the decision-making framework, strategies, and software used to successfully deploy the first combined chronic pain and opioid use data clinical trial data commons using...
3.
Arledge C, Zhao A, Topaloglu U, Zhao D
medRxiv
. 2024 Sep;
PMID: 39281733
Dynamic contrast enhanced (DCE) MRI is a non-invasive imaging technique that has become a quantitative standard for assessing tumor microvascular permeability. Through the application of a pharmacokinetic (PK) model to...
4.
Smith M, Dixon C, Wang Y, Liu Y, DAgostino Jr R, Ruiz J, et al.
Cancer Res
. 2024 Sep;
84(23):4002-4016.
PMID: 39250241
Treatment of non-small cell lung cancer (NSCLC) has drastically changed in recent years owing to the robust anticancer effects of immune checkpoint inhibitors (ICI). However, only 20% of the patients...
5.
Smith M, Wang Y, Dixon C, DAgostino R, Liu Y, Ruiz J, et al.
Clin Lung Cancer
. 2024 Aug;
25(8):e379-e388.
PMID: 39095235
Objectives: Compared to low-grade irAEs, high-grade irAEs are more often dose-limiting and can alter the long-term treatment options for a patient. Predicting the incidence of high-grade irAEs would help with...
6.
Lee L, Coelho D, Manzoor N, Wilcox A, Lee A, Graves A, et al.
Otol Neurotol Open
. 2024 Jun;
4(2):e051.
PMID: 38919767
Objective: Determine the incidence of vestibular disorders in patients with SARS-CoV-2 compared to the control population. Study Design: Retrospective. Setting: Clinical data in the National COVID Cohort Collaborative database (N3C)....
7.
Ay S, Cardei M, Meyer A, Zhang W, Topaloglu U
J Healthc Inform Res
. 2024 Apr;
8(2):225-243.
PMID: 38681756
Deep learning (DL) has gained prominence in healthcare for its ability to facilitate early diagnosis, treatment identification with associated prognosis, and varying patient outcome predictions. However, because of highly variable...
8.
Adams M, Hurley R, Topaloglu U
Subst Use Addctn J
. 2024 Mar;
46(1):141-145.
PMID: 38516882
The National Institutes of Health (NIH) has developed the NIH HEAL Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR) network to address the interconnected nature of chronic...
9.
Mitra A, Mukherjee U, Mazumder S, Madhira V, Bergquist T, Shao Y, et al.
Blood Cancer J
. 2023 Dec;
13(1):180.
PMID: 38057320
Patients with multiple myeloma (MM), an age-dependent neoplasm of antibody-producing plasma cells, have compromised immune systems and might be at increased risk for severe COVID-19 outcomes. This study characterizes risk...
10.
Bitterman D, Gensheimer M, Jaffray D, Pryma D, Jiang S, Morin O, et al.
JCO Clin Cancer Inform
. 2023 Dec;
7:e2300136.
PMID: 38055914
In August 2022, the Cancer Informatics for Cancer Centers brought together cancer informatics leaders for its biannual symposium, Precision Medicine Applications in Radiation Oncology, co-chaired by Quynh-Thu Le, MD (Stanford...